Products of other enterprises
Technical characteristics
- BrandJia Ye
- Country of manufactureChina
- MFC17H26N2O.ClH.H2O
- MW328.88
- Appearancewhite to off-white crystal or crystalline powder
- CAS132112-35-7
Description
Ropivacaine HCL
CAS: 132112-35-7
MF: C17H26N2O.ClH.H2O
MW: 328.88
Appearance: white to off-white crystal or crystalline powder
Usage:
Ropivacaine is indicated for local anaesthesia including infiltration, nerve block, epidural and intrathecal anaesthesia in adults and children over 12 years. It is also indicated for peripheral nerve block and caudal epidural in children 1-12 years for surgical pain. It is also sometimes used for infiltration anaesthesia for surgical pain in children.
Ropivacaine is often coadministered for epidural analgesia, for example in pregnant women during labour.
| oduct | ROPIVACAINE HCL 132112-35-7 |
Quantity | 195KG | ||||||||
| Batch No. | 13102602 | Mfg. Date | 2013.10.26 | ||||||||
| Test Date | 2013.10.29 | Exp. Date | 2015.10.25 | ||||||||
| Tests | Results | Specifications | |||||||||
| Description | Complies | White,crystalline powder | |||||||||
| Solubility | Complies | Soluble in water | |||||||||
| Identification | Complies | A: By IR, To match with working standard A: IR |
|||||||||
| Complies | B: Test for chlorides. Reponds to the test for Chlorides. B: |
||||||||||
| Bacterial endotoxins | Complies | Meets the requirements | |||||||||
| Colour | 0.009 | The absorbance at 405nm is not more than 0.030 405nm0.030 |
|||||||||
| 0.007 | The absorbance at 436nm is not more than 0.025. 436nm0.025 |
||||||||||
| Clarity | Complies | Meets the requirements | |||||||||
| Specific rotation | -249° | -210°~ -255° | |||||||||
| pH | 4.95 | 4.5 ~ 6.0 | |||||||||
| Water | 5.59% | 5.0%~6.0% | |||||||||
| Heavy metal | <0.001% | ≤ 0.001% | |||||||||
| Limit of ropivacaine related compound A A |
Complies | ≤ 10μg/g | |||||||||
| Related compounds | Bupivacaine | 0.006% | ≤ 0.2% | ||||||||
| Any other individual impurity | <0.1% | ≤ 0.1% | |||||||||
| Total impurities | 0.01% | ≤ 0.5% | |||||||||
| Enantiomeric purity | Not detect | ≤ 0.5% | |||||||||
| Residual Solvents | Complies | Meets the requirements | |||||||||
| Assay | 100.41% | 98.5~101.0% | |||||||||
| Conclusion : Conforms to USP35 USP35 |
|||||||||||
Contact the seller
Ropivacaine HCL
We recommend to see